Clinical Trials in Cosenza, Italy
6 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1153 locationsNCT07064473
Recruiting
Phase 3
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Multiple Myeloma
European Myeloma Network B.V.1,594 enrolled210 locationsNCT05243797
Recruiting
Phase 3
Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
Acute Lymphoblastic Leukemia, Pediatric
Martin Schrappe5,000 enrolled115 locationsNCT03643276
Recruiting
Phase 3
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Lymphoblastic Lymphoma, Childhood
University Hospital Muenster683 enrolled228 locationsNCT04043494
Recruiting
Study to Assess Effectiveness and Safety of Zanubrutinib for Patients With Marginal Zone Lymphoma Treated in Italy Under the Named Patient Program (NPP)
Marginal Zone Lymphoma (MZL)
IRCCS Azienda Ospedaliero-Universitaria di Bologna59 enrolled15 locationsNCT06823960
Recruiting
Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy
Chronic Lymphocytic LeukemiaRefractory LeukemiaRelapse Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto321 enrolled27 locationsNCT04282811
Recruiting
Phase 3
High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)
Neuroblastoma
St. Anna Kinderkrebsforschung3,300 enrolled126 locationsNCT01704716